SEI Investments
ADCT icon

SEI Investments’s ADC Therapeutics ADCT Stock Holding History

SEI Investments’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8K Hold
33,461
– – ﹤0.01% 3244
2026
Q1 		$125K Buy
33,461
+10,472
+46% +$41.3K ﹤0.01% 3058
2025
Q4 		$81.2K Hold
22,989
– – ﹤0.01% 3035
2025
Q3 		$92K Hold
22,989
– – ﹤0.01% 2728
2025
Q2 		$61.6K Hold
22,989
– – ﹤0.01% 2736
2025
Q1 		$32.4K Hold
22,989
– – ﹤0.01% 2711
2024
Q4 		$45.7K Buy
+22,989
New +$60.2K ﹤0.01% 2675

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SEI Investments's ADCT Position: Q2 2026 in Review

SEI Investments held its ADC Therapeutics (ADCT) position steady in Q2 2026 at 33,461 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3244.

SEI Investments first reported a position in ADCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $125K in Q1 2026. 113 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • SEI Investments held 33,461 shares of ADC Therapeutics worth $35.8K as of Q2 2026.
  • SEI Investments left its ADC Therapeutics share count unchanged in Q2 2026.
  • ADC Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3244 holding.
  • SEI Investments first reported a position in ADC Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SEI Investments's ADC Therapeutics position peaked at $125K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.